These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 16563920)

  • 1. Differential effects between intravenous and targeted renal delivery of fenoldopam on renal function and blood pressure in patients undergoing cardiac catheterization.
    Teirstein PS; Price MJ; Mathur VS; Madyoon H; Sawhney N; Baim DS
    Am J Cardiol; 2006 Apr; 97(7):1076-81. PubMed ID: 16563920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of fenoldopam on renal haemodynamics and natriuresis in chronic renal failure.
    de Fijter CW; Comans EF; de Vries PM; Oe PL; Roos JC; Smit AJ; Streurman O; Donker AJ
    Neth J Med; 1990 Jun; 36(5-6):267-78. PubMed ID: 1975651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison between fenoldopam and low-dose dopamine in early renal dysfunction of critically ill patients.
    Brienza N; Malcangi V; Dalfino L; Trerotoli P; Guagliardi C; Bortone D; Faconda G; Ribezzi M; Ancona G; Bruno F; Fiore T
    Crit Care Med; 2006 Mar; 34(3):707-14. PubMed ID: 16505657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of fenoldopam infusion in complex cardiac surgical operations: a prospective, randomized, double-blind, placebo-controlled study.
    Ranucci M; De Benedetti D; Bianchini C; Castelvecchio S; Ballotta A; Frigiola A; Menicanti L
    Minerva Anestesiol; 2010 Apr; 76(4):249-59. PubMed ID: 20332738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective renal arterial infusion of fenoldopam for the prevention of contrast-induced nephropathy.
    Ng MK; Tremmel J; Fitzgerald PJ; Fearon WF
    J Interv Cardiol; 2006 Feb; 19(1):75-9. PubMed ID: 16483344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained hemodynamic effects of the selective dopamine-1 agonist, fenoldopam, during 48-hour infusions in hypertensive patients: a dose-tolerability study.
    Taylor AA; Mangoo-Karim R; Ballard KD; Luther RR; Pool JL
    J Clin Pharmacol; 1999 May; 39(5):471-9. PubMed ID: 10234594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-acetylcysteine and fenoldopam protect the renal function of patients with chronic renal insufficiency undergoing cardiac surgery.
    Barr LF; Kolodner K
    Crit Care Med; 2008 May; 36(5):1427-35. PubMed ID: 18434903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of fenoldopam on coronary conduit blood flow after coronary artery bypass graft surgery.
    Halpenny M; Lakshmi S; O'Donnell A; O'Callaghan-Enright S; O'Connell D; Shorten G
    J Cardiothorac Vasc Anesth; 2001 Feb; 15(1):72-6. PubMed ID: 11254844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and rationale of CONTRAST--a prospective, randomized, placebo-controlled trial of fenoldopam mesylate for the prevention of radiocontrast nephropathy.
    Stone GW; Tumlin JA; Madyoon H; Lepor NE; McCullough PA; Mathur VS; Murray PT; O'Neill WW
    Rev Cardiovasc Med; 2001; 2 Suppl 1():S31-6. PubMed ID: 12439366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of fenoldopam and dopexamine on hepatic blood flow and hepatic function following coronary artery bypass grafting with hypothermic cardiopulmonary bypass.
    Adluri RK; Singh AV; Skoyles J; Robins A; Hitch A; Baker M; Mitchell IM
    Eur J Cardiothorac Surg; 2009 Jun; 35(6):988-94. PubMed ID: 19406658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired blood flow in acute kidney injury: pathophysiology and potential efficacy of intrarenal vasodilator therapy.
    Tumlin JA
    Curr Opin Crit Care; 2009 Dec; 15(6):514-9. PubMed ID: 19829105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local intra-renal fenoldopam infusion causes greater increases in renal artery flow velocity than systemic intravenous fenoldopam infusion: a pilot study.
    Grube E; Baim D; Burkhoff D; Mueller R; Buellesfeld L; Teirstein P
    EuroIntervention; 2005 Nov; 1(3):305-8. PubMed ID: 19758921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multifactorial acute renal failure treated with percutaneous targeted renal therapy (TRT): a case of "dialysis rescue".
    Allie DE; Hebert CJ; Walker CM
    J Invasive Cardiol; 2007 Feb; 19(2):E27-30. PubMed ID: 17268046
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of various fenoldopam doses on renal perfusion in patients undergoing cardiac surgery.
    Meco M; Cirri S
    Ann Thorac Surg; 2010 Feb; 89(2):497-503. PubMed ID: 20103330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
    Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W
    Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrast-induced nephropathy: protective role of fenoldopam.
    Caixeta A; Dogan O; Weisz G
    Clin Exp Pharmacol Physiol; 2012 Jun; 39(6):497-505. PubMed ID: 22642656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative renal effects of intravenous administration of fenoldopam mesylate and sodium nitroprusside in patients with severe hypertension.
    White WB; Halley SE
    Arch Intern Med; 1989 Apr; 149(4):870-4. PubMed ID: 2565105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of renal flow and flow reserve in humans.
    Manoharan G; Pijls NH; Lameire N; Verhamme K; Heyndrickx GR; Barbato E; Wijns W; Madaric J; Tielbeele X; Bartunek J; De Bruyne B
    J Am Coll Cardiol; 2006 Feb; 47(3):620-5. PubMed ID: 16458147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of sodium nitroprusside infusion on renal function during reperfusion period in patients undergoing coronary artery bypass grafting: a prospective randomized clinical trial.
    Kaya K; Oğuz M; Akar AR; Durdu S; Aslan A; Erturk S; Taşöz R; Ozyurda U
    Eur J Cardiothorac Surg; 2007 Feb; 31(2):290-7. PubMed ID: 17174559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of intravenous nitroglycerin after administration of sildenafil citrate to men with coronary artery disease: a double-blind, placebo-controlled, randomized, crossover trial.
    Parker JD; Bart BA; Webb DJ; Koren MJ; Siegel RL; Wang H; Malhotra B; Jen F; Glue P
    Crit Care Med; 2007 Aug; 35(8):1863-8. PubMed ID: 17522570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.